Olink

Olink®
Part of Thermo Fisher Scientific

Plasma proteomics for prediction of subclinical coronary artery calcifications in primary prevention

American Heart Journal, 2024

Royer P., Björnson E., Adiels M., Álvez M., Fagerberg L., Bäckhed F., Uhlén M., Gummesson A., Bergström G.

Disease areaApplication areaSample typeProducts
Immunological & Inflammatory Diseases
Pathophysiology
Plasma
Olink Explore 3072/384

Olink Explore 3072/384

Abstract

The measles, mumps and rubella (MMR) vaccine protects against all-cause mortality in children, but the immunological mechanisms mediating these effects are poorly known. We systematically investigated whether MMR can induce long-term functional changes in innate immune cells, a process termed trained immunity, that could at least partially mediate this heterologous protection. In a randomized placebo-controlled trial, 39 healthy adults received either the MMR vaccine or a placebo. By using single-cell RNA-sequencing, we found that MMR caused transcriptomic changes in CD14-positive monocytes and NK cells, but most profoundly in γδ T cells. Monocyte function was not altered by MMR vaccination. In contrast, the function of γδ T cells was markedly enhanced by MMR vaccination, with higher production of TNF and IFNγ, as well as upregulation of cellular metabolic pathways. In conclusion, we describe a trained immunity program characterized by modulation of γδ T cell function induced by MMR vaccination.

Read publication ↗